BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7427380)

  • 1. Comparison of two combination chemotherapy regimens in advanced colorectal cancer.
    Epenetos AA; Amos C; Collis C; Slevin M; Rohatiner A; Baille-Johnson H; Pitts J; Wrigley PF
    Br Med J; 1980 Aug; 281(6240):587-8. PubMed ID: 7427380
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A; Kolarić K
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract]   [Full Text] [Related]  

  • 3. Colorectal cancer. Chemotherapy.
    Whitehouse JM
    Recent Results Cancer Res; 1982; 83():126-34. PubMed ID: 7134615
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
    Joss RA; Goldberg RS; Yates JW
    Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of cancer of the large intestine].
    PlatinskiÄ­ LV; Sokolova VD; Ozhiganov EL
    Sov Med; 1985; (3):51-8. PubMed ID: 3895460
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
    Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
    Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
    Davis S; Park YK
    Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of colorectal carcinoma.
    Woolley PV; Macdonald JS; Schein PS
    Semin Oncol; 1976 Dec; 3(4):415-20. PubMed ID: 136751
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.
    Craig JB; Jackson DV; Richards FR; Muss HB; White DR; Cooper MR; Stuart JJ; Spurr CL
    Am J Clin Oncol; 1987 Feb; 10(1):44-6. PubMed ID: 3825991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.